Procedimentos Operacionais Padrão – POP – NANoREG

NANoREG D5 05 DR Report on cell type and in vitro in vivo correlation studies for inhalation toxicity

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d5-05-dr-report-on-cell-type-and-in-vitro-in-vivo-correlation-studies-for 

NANoREG D5 04 DR In vitro screening methodology to evaluate toxicity by inhalation

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d5-04-dr-in-vitro-screening-methodology-to-evaluate-toxicity-by-inhalation 

NANoREG D5.03 DR In vitro screening methodology for absorption or crossing of other barriers

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d503-dr-in-vitro-screening-methodology-for-absorption-or-crossing-of-other 

SOPs available in deliverable:

• SOP 01 Protocol for organotypic cell culture modified for exposure to nanomaterials
• SOP 02 Caco-2 cell culture and differentiation
• SOP 03 Evaluation of NMs impact on Caco-2 cell barrier model

NANoREG D5 02 DR Report on the development of a solubility testing procedure

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d5-02-dr-report-on-development-of-solubility-testing-procedure 

NANoREG D5 01 DR Report on identification and setting of categorization read across and extra intrapolation criteria

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d5-01-dr-report-on-identification-and-setting-of-categorization-read-across-and 

NANoREG D4.18 DR Overall evaluation of data, publication, and transfer to OECD sponsorship programme

Acesse:

https://www.rivm.nl/documenten/nanoreg-d418-dr-overall-evaluation-of-data-publication-and-transfer-to-oecd-sponsorship 

NANoREG D4 17 DR Development of PBPK models

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d4-17-dr-development-of-pbpk-models 

NANoREG D4 16 DR Immunotoxic and genotoxic effects after short term inhalation of fibrous nanomaterials

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d4-16-dr-immunotoxic-and-genotoxic-effects-after-short-term-inhalation-of 

NANoREG D4 15 DR Protocol for inhalation exposure and choice of biological relevant endpoints

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d4-15-dr-protocol-for-inhalation-exposure-and-choice-of-biological-relevant 

NANoREG D4.14 DR Prenatal toxicity study with cerium oxide and MWCNT carbon nanotubes

Acesse:

https://www.rivm.nl/documenten/nanoreg-d414-dr-prenatal-toxicity-study-with-cerium-oxide-and-mwcnt-carbon-nanotubes